Biocon Ltd.
Healthcare
Biocon may list biosimilars business by 2025 first half: CEO
Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to the company's total revenue, ......
Healthcare
Advent may rope in new investor for Bharat Serums with neat valuation markup
Mumbai-based biopharmaceutical company Bharat Serums, controlled by private equity major Advent International, is looking to onboard new investor(s) for a ......
Healthcare
Serum to double investment in PE-backed Biocon Biologics to $300 mn
A unit of Adar Poonawalla-led Serum Institute of India, the world's biggest vaccine maker, will double its investment to $300 ......
Healthcare
Kotak wraps up investments from $1 bn special situations fund with new deal
Kotak Special Situations Fund (KSSF), part of Kotak Mahindra Group’s alternative asset management arm, has completed the deployment of its ......
Healthcare
Biocon Biologics valued at over $4 bn with ADQ investment
Abu Dhabi’s state entity ADQ, formerly known as Abu Dhabi Developmental Holding Company, will invest Rs 555 crore ($75.6 million) ......
Infrastructure
Biocon to pick up 26% stake in renewables firm
Biocon Ltd on Monday said it has agreed to pick up a 26% stake in a renewables firm as the ......
General
Why Pfizer vaccine brings little cheer to coronavirus-hit India
Despite hopes raised by Pfizer's COVID-19 vaccine, it will take huge efforts for India to defeat the coronavirus, with its ......
Healthcare
Biocon Biologics gets third PE cheque this year as Goldman bets $150 mn
Biopharmaceuticals company Biocon Ltd’s biosimilars unit is getting a big funding cheque from Goldman Sachs, after roping in private equity ......
Healthcare
True North looks to back former Biocon execs' drug research firm
Homegrown private equity firm True North is in advanced negotiations to pick up a stake in a pharmaceutical research and ......
Healthcare
Tata Capital PE fund to invest in Biocon subsidiary
Biopharmaceuticals company Biocon Ltd has attracted another private equity firm to invest in its biosimilar unit just months after getting ......
